FIGURE 1.
Structures of the 1,5-benzodiazepine ligands for the CCK1R used in the current study. Note the key differences in the N1-isopropyl group of the full agonist, GI181771X (A), that are present in the other two compounds, GR134056X that contains a hydrogen in this position (B) and GR135470X that contains a methyl group in this position (C).